Bryan Johnson’s rigid Blueprint protocol—encompassing an 8:30 p.m. bedtime, solo sleeping, and tightly controlled daily schedule—has driven near-unanimous trader consensus toward “No” at 100% implied probability for the market resolving by May 31. Public disclosures of intimacy with partner and co-founder Kate Tolo occur only sporadically, typically tied to biomarker updates or educational threads rather than routine confirmation, and no such catalyst materialized in the final window. Historical patterns show announcements cluster around health metrics or interviews, leaving insufficient time for the explicit public statement required. Realistic upset scenarios remain limited to an unexpected late X post or podcast segment before the deadline, though the protocol’s constraints and lack of scheduled events make such shifts improbable.